Daily Stock Market Outlook Report by Imperial Money Pvt. Ltd. of 10th Feb, 2021. Download Free Report Now!!! Nifty opened with positive gap up today at 17,554.10 on 10th Feb 2022, index was very bullish and made a day high of 17,639.45 and closed positive at very important level 17,605.85. Resistance for nifty is18,000 and support is 17,350 (Closing Basis). Index may test 19200 in coming days.

1. MARKET OUTLOOK REPORT
Figure. Nifty50 Intraday chart
Index Previous close Open High Low Close Change %
Nifty 50 17,463.8 17,554.10 17,639.45 17,427.15 17,605.85 0.81%
Sensex 58,465.97 58,810.53 59,060.24 58,332.28 58,926.03 0.79%
Nifty opened with positive
gap up today at 17,554.10
on 10th
Feb 2022, index
was very bullish and made
a day high of 17,639.45
and closed positive at very
important level 17,605.85.
Resistance for nifty is
18,000 and support is
17,350 (Closing Basis).
Index may test 19200 in
coming days.
www.imperialfin.com wecare@imperialfin.com +91-9595889988
10th
FEB 2022

2. Sectorial Performance
0.35%
1.02%
0.32%
1.16%
1.04%
0.05%
0.59%
0.90%
1.24%
NIFTYFMCG
NIFTYIT
NIFTYPHARMA
NIFTYFINSERVICE
NIFTYBANK
NIFTYAUTO
NIFTYMEDIA
NIFTYREALTY
NIFTYMETAL
SECTORS CHANGE %
SECTORS CHANGE %
www.imperialfin.com wecare@imperialfin.com +91-9595889988
10th
FEB 2022

3. Top Trending News
 SJVN:
CO APPROVED INTERIM DIVIDEND OF RUPEES 1.15 PER EQUITY SHARE
 RASHTRIYA CHEMICALS & FERTILIZERS:
Q3 SL NET PROFIT 1.42B RUPEES VS 981M (YOY) | 1.16B (QOQ) || Q3 REVENUE 36.99B RUPEES VS 20.5B (YOY); 26.12B
(QOQ)
 HEALTHCARE GLOBAL ENTERPRISES:
Q3 CONS NET LOSS 457.8M RUPEES VS LOSS 292.5M (YOY) | PROFIT 1.03B (QOQ) || Q3 REVENUE 3.57B RUPEES VS
2.73B (YOY); 3.5B (QOQ)
 AMARA RAJA BATTERIES:
Q3 REVENUE RUPEES 23.65B VS 19.6B (YOY); 22.64B (QOQ)
 STRIDES PHARMA:
CO UPDATED REGARDING SCHEME OF AMALGAMATION FOR MERGER OF VIVIMED LIFE SCIENCES PRIVATE LTD, A
WHOLLY OWNED SUBSIDIARY, WITH THE CO
 CAMS:
CO APPROVED DIVIDEND OF RUPEES 10.75/ SHARE
10th
FEB 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

4. 5.86%
4.32% 4.15% 4.01%
3.14%
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
7.00%
JINDALSTEL AUROPHARMA ADANITRANS DMART ONGC
TOP GAINERS
2.24%
2.08%
1.92%
1.77% 1.65%
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
GLAND AMBUJACEM PNB YESBANK ICICIGI
TOP LOSERS
Stocks in Action
www.imperialfin.com wecare@imperialfin.com +91-9595889988
10th
FEB 2022

5. Corporate Actions
 BPCL (Interim Dividend Rs. 5 per share on 10th
Feb)
 VRLOG (Interim Dividend Rs. 8 per share on 10th
Feb)
FII/DII/FPI ACTION IN CAPITAL MARKET
Category Date Buy Value Sell Value Net Value
DII 9 Feb 2021 7021.37 cr 5228.02 cr 1793.35 cr
FII/FPI 9 Feb 2021 6152.38 cr 7045.02 cr -892.64 cr
 The following is combined Domestic Institutional Investors trading data across NSE, BSE and MSEI
collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System.
10th
FEB 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

6. MANALIPETC. Sector:Chemicals.
Important Parameter
MARKET CAP P/B EPS BOOK VALUE PE ROE ROCE
1,938.43 CR 2.33 21.60 48.38 5.22 35.23% 46.89%
FUNDAMENTALS.
 The company has shown a good profit growth of 51.97% for the Past 3 years.
 Company has been maintaining healthy ROCE of 27.39% over the past 3 years.
 Company is virtually debt free.
 Company has a healthy Interest coverage ratio of 59.20.
Stock Entry price Positional
target
MANALIPETC 112 160
www.imperialfin.com wecare@imperialfin.com +91-9595889988
10th
FEB 2022

7. Disclaimer
This document has been prepared for IMPERIAL MONEY PVT. LTD. by Mr. Praveen Dubey NISM (201800048686) is a Research Consultant for Imperial Money Pvt. Ltd. This Market Outlook is
intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any
review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. Imperial Money Pvt. Ltd. Does not carry any responsibility in case to whomsoever using the information of this newsletter content and data
www.imperialfin.com wecare@imperialfin.com +91-9595889988
10th
FEB 2022